Lung cancer chemotherapy, new treatment and related patents
The majority of patients with lung cancer present with advanced stage which contributes to death of more people than any other malignancy in the world. The discovery of a number of lung cancer-molecular alterations contributes to uniquely targeted therapies with specific inhibitors for non-small cel...
Saved in:
Main Authors: | Cheepsattayakorn,A., Cheepsattayakorn,R. |
---|---|
格式: | Article |
出版: |
Bentham Science Publishers B.V.
2015
|
主題: | |
在線閱讀: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84905667813&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38293 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells
由: Moltira Promkan, et al.
出版: (2014) -
Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
由: Jitawatanarat,P., et al.
出版: (2015) -
In vitro anti-proliferative activity on colon cancer cell line (HT-29) of Thai medicinal plants selected from Thai/Lanna medicinal plant recipe database "MANOSROI III"
由: Manosroi,A., et al.
出版: (2015) -
Novel compounds and drugs and recent patents in treating multidrug-resistant and extensively drug-resistant tuberculosis
由: Attapon Cheepsattayakorn, et al.
出版: (2018) -
Investigation of anti-inflammatory, antinociceptive and antipyretic activities of Stahlianthus involucratus rhizome ethanol extract
由: Pingsusaen,P., et al.
出版: (2015)